The Pros, Cons, and Considerations of Taking Ozempic and Other GLP-1 Drugs for Weight Loss

The Pros, Cons, and Considerations of Taking Ozempic or Other Drugs for Weight Loss

The Pros, Cons, and Considerations of Taking Ozempic or Other Drugs for Weight Loss
Jason Bergman/AP Photo

Many people who have struggled to lose weight their entire lives have found the new generation of GLP-1 weight loss drugs exceptionally helpful. But if you’ve been considering asking your doctor for a prescription, there are some things you should know first.

Here’s what experts say about research on the effectiveness of semaglutide (Ozempic, Wegovy); the similar GIP/GLP-1 medication, tirzepatide (Mounjaro, Zepbound); and the new nonpeptide GLP-1, orforglipron (Foundayo). Plus, learn more about when to consider them for weight loss.

How Ozempic and GLP-1 Drugs Work

Ozempic and similar drugs have several functions that make them helpful for managing diabetes and weight loss.

Decreasing Hunger and Increasing Satiety

Many weight loss drugs of the past had questionable results, but semaglutide, tirzepatide, and orforglipron may be game changers for weight management.

“These newer medications work on a different physiologic pathway from some of the other medications,” says Kimberly Gudzune, MD, MPH, associate professor of medicine at Johns Hopkins Bloomberg School of Public Health and director of the Johns Hopkins Healthy Eating, Activity & Weight Program in Baltimore. Whereas some anti-obesity drugs decrease the amount of dietary fat the body absorbs, semaglutide and other GLP-1 medications affect hormones involved in hunger and satiety.

Controlling hunger can help support weight loss. According to one small study of adults with obesity in a weight loss program, greater hunger was significantly linked with consuming more calories.

Lowering Blood Sugar and Slowing Digestion

Semaglutide, tirzepatide, and orforglipron mimic the natural hormone glucagon-like peptide 1 (GLP-1), which helps regulate hunger and feelings of fullness. GLP-1 also lowers blood sugar levels by helping the pancreas produce more insulin, thus preventing the liver from releasing too much sugar and slowing the rate at which food travels through the digestive system.

Quieting Food Noise

Dr. Gudzune has patients taking GLP-1 medications who have reported feeling full on smaller portions, and many describe a reduction in “food noise” (ever-present thoughts about eating and food). Emerging research supports this, though research is frequently funded by pharmaceutical and other industry companies.

Lowering Body Weight

According to the American Diabetes Association, lowering blood sugar and slowing digestion are important steps for managing diabetes, a condition in which an inability to make or properly use insulin severely reduces blood sugar control.

Evidence also shows that medications like semaglutide, tirzepatide, and orforglipron are much more efficacious, meaning they lead to a higher total body weight loss more quickly than other medications that clinicians have historically prescribed to treat obesity, says Rekha Kumar, MD, associate professor of clinical medicine and attending endocrinologist at Weill Cornell Medical College in New York City.

Several studies have shown that semaglutide can have a profound impact on body weight. One large study showed that more than 1 in 4 people who took the drug for a year lost 20 percent or more of their weight (though it’s worth noting the study was paid for by the maker of Wegovy).

Research has also reported that people who took tirzepatide lost nearly 20 percent of their body weight.

 And a significant number of people who took orforglipron lost 15 percent or more body weight, according to a meta-analysis of five randomized controlled trials.

Semaglutide and Similar Medications for Weight Loss

While semaglutide and other GLP-1 medications are quite effective for weight loss, not everyone is a suitable candidate for them. Doctors primarily prescribe Ozempic as a diabetes treatment. But the U.S. Food and Drug Administration (FDA) has approved the same drug as an overweight and obesity treatment under the brand name Wegovy.

A similar drug, tirzepatide, is sold as Mounjaro for diabetes and also received FDA approval in November 2023 to treat obesity under the brand name Zepbound. A meta-analysis of three randomized controlled trials showed that tirzepatide helped 74 percent or more of people lose at least 15 percent of their body weight. And 1 in 4 participants lost nearly 40 percent.

The newest medication to receive FDA approval for weight loss is orforglipron, an oral medication sold under the brand name Foundayo that you can take without food and water restrictions. Even smaller doses of 3 milligrams (mg) of orforglipron may be able to help with weight loss, though research suggests that doses of 24 mg or more may be needed for more significant weight loss.

Who Should Use Ozempic or Similar Medications for Weight Loss?

Wegovy is FDA approved to treat both adults and children 12 years and older with obesity. Wegovy, Zepbound, and Foundayo have approval to treat adults with a body mass index (BMI) of 30 or higher as well as adults who are overweight and have weight-related health issues.

Ozempic and Mounjaro can be used off-label for weight loss in the absence of a health condition for certain patients with qualifying criteria, but that doesn’t mean it’s a good idea. For starters, these drugs may be useful for weight loss only if your BMI is higher than 30, or if your BMI is higher than 27 and you have type 2 diabetes, high blood pressure, or another weight-related health condition.

In addition, if you use semaglutide, tirzepatide, or orforglipron, that doesn’t mean you can forget about following a healthy lifestyle. “People should always pursue a healthy diet for their overall cardiometabolic health and for adequate nutritional status,” says Dr. Kumar. “No medication or supplement can counteract the effects of a bad diet.” Regular exercise, good hydration, and quality sleep are other habits crucial for overall health and better weight loss results.

As for who is a good candidate for these drugs, there are no official criteria. “Right now we use BMI combined with other medical conditions to determine eligibility for a medication,” says Gudzune. She says that anyone with a BMI of 30 or greater or anyone who has a BMI of at least 27 plus another weight-associated medical condition (such as high blood pressure) is a potential candidate for medication. But it’s important for anyone considering medicated weight loss to discuss the options with a knowledgeable healthcare provider.

The Realities of Weight Loss

If you’ve attempted weight loss in the past only to find pounds creeping back onto your frame, you know that it’s rarely easy.

“Obesity is a complex condition — so many factors contribute to its occurrence (and reoccurrence) over time, and these factors are not the same for all people,” says Gudzune.

It can be frustrating and discouraging when someone repeatedly fails at weight loss or loses only to regain. These new classes of drugs have been giving those people hope. “For people who have not had success with lifestyle alone or have been previously unsuccessful with other medications, these medications offer a new option that may support their health goals,” Gudzune says.

But some celebrities and people who may not really need them are using the weight loss medications somewhat inappropriately. While these folks may talk a lot about their success with Ozempic for weight loss, it’s important to remember that no one strategy is a magic bullet for shedding pounds.

Side Effects and Other Factors to Consider

If you do decide to give Ozempic or another similar medication a try, be aware that while they may seem like miracle drugs, they are not without downsides. Here are some factors to consider.

Cost

Depending on your insurance coverage, GLP-1 medications can be quite expensive. According to the Association of American Medical Colleges, Wegovy injections can cost $1,349 per month, depending on insurance coverage. Zepbound runs slightly less, at $1,086 monthly. Drug manufacturers offer self-pay options that can lower this to $299 to $349 a month for Wegovy maintenance doses and $499 for monthly Zepbound shots, for instance.

Delivery Method

Afraid of needles? Most of these medications are delivered via injection, but Wegovy and Foundayo are FDA approved oral GLP-1s.

Treatment Length

Once you start taking weight loss medications, you’ll likely need to stay on them to maintain results. “Patients considering any anti-obesity medication as a treatment option should be prepared to take these medications long term — [that’s how] we see the best outcomes in the scenario for achieving and, most importantly, sustaining all the health benefits achieved,” says Gudzune.

Side Effects

Gastrointestinal (GI) complaints are the most common type of side effect. Up to 60 percent of people taking GLP-1 medications experience GI side effects, though these tend to lessen over time. They may include:

Other side effects may include:

  • Dizziness
  • Increased heart rate
  • Infection
  • Headaches
  • Mild itchiness or redness at the injection site

Your Other Health Conditions

Tell your doctor if you’ve had problems with your kidneys or pancreas, if you have a history of diabetic retinopathy, or if you are pregnant, breastfeeding, or plan to be. These conditions may affect whether you can use this drug.

Some evidence suggests that people with certain other medical conditions should avoid these drugs, too. “People who have a history or family history of a rare thyroid cancer (medullary thyroid carcinoma) should not use this medication,” says Gudzune. Similarly, anyone with a history of pancreatitis should discuss the safety of these medications with a healthcare provider.

Finally, individuals with a history of disordered eating should discuss the drugs with their doctor and therapist before starting.

Unknowns

As prescription drugs go, semaglutide and tirzepatide are relatively new, so there’s a lot we still don’t know about them. Studies have not documented the effects of decades-long use of semaglutide, tirzepatide, or orforglipron.

Kumar points out that there’s minimal research on their effects on people with normal weight. “While it is true that taking [these drugs] may benefit those with overweight or obesity, testing hasn’t assessed the effects of Ozempic in those without obesity — meaning people who want to lose those extra ‘vanity pounds.’ So there’s no way to know what sort of weight loss or side effects can happen with inappropriate use.”

Remember, too, that as effective as these medications may be, they can’t solve emotional issues related to eating and weight. Depending on your relationship to food, it may be best to approach weight loss from a more comprehensive perspective that addresses the physical and the emotional.

Resources We Trust

Diala Alatassi, MD, FACP

Medical Reviewer

Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care. By integrating medical exper...

Sarah-Garone-bio

Sarah Garone

Author
Sarah Garone is a licensed nutritionist, registered nutrition and dietetics technician, freelance health and wellness writer, and food blogger in Mesa, Arizona. She has written for...
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Weight Loss Medications. Cleveland Clinic. September 12, 2025.
  2. Ugwoaba UA et al. Hunger, Temptation, and Dietary Adherence During Weight Management. Eating Behaviors. May 20, 2023.
  3. Mahapatra MK et al. Semaglutide, a Glucagon Like Peptide-1 Receptor Agonist With Cardiovascular Benefits for Management of Type 2 Diabetes. Reviews in Endocrine & Metabolic Disorders. January 7, 2022.
  4. Cook G. Quieting "Food Noise": How GLP-1s and Mindfulness Rewire the Default Mode Network (DMN) and Reward Circuits. Cureus. January 5, 2026.
  5. How Does Food Impact Blood Glucose? American Diabetes Association. December 18, 2025.
  6. Ruseva A et al. Semaglutide 2.4 MG Long-Term Clinical Outcomes in Patients With Obesity or Overweight: A Real-World Retrospective Cohort Study in the United States (Scope 12 Months). Postgraduate Medicine. March 27, 2025.
  7. Lui L et al. Efficacy and Safety of Tirzepatide Versus Placebo in Overweight or Obese Adults Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Clinical Pharmacy. July 22, 2024.
  8. Tantoush M et al. Comparative Efficacy and Safety of Different Orforglipron Doses in Patients With Type 2 Diabetes Mellitus and Obesity: A Systematic Review and Network Meta-Analysis. Cureus. January 21, 2026.
  9. Top Weight Loss Medications. Obesity Medicine Association. April 2, 2026.
  10. Prescription Medications to Treat Overweight & Obesity. National Institute of Diabetes and Digestive and Kidney Diseases. June 2024.
  11. Balch B. GLP-1 Pills for Weight Loss are Here. How Will They Change Obesity Care? Association of American Medical Colleges. March 5, 2026.
  12. Kim JA et al. Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning. Diabetes & Metabolism Journal. July 1, 2025.
  13. GLP-1 Agonists. Cleveland Clinic. July 3, 2023.